5 Most Undervalued Biotech Stocks To Buy According To Hedge Funds

4. Dynavax Technologies Corporation (NASDAQ:DVAX)

Number of Hedge Fund Holders: 22

PE Ratio as of February 8: 5.78

California-based Dynavax Technologies Corporation (NASDAQ:DVAX) ranks 4th in our list of the most undervalued biotech stocks to buy according to hedge funds. Insider Monkey’s database shows that 22 hedge funds had stakes in Dynavax Technologies Corporation (NASDAQ:DVAX) at the end of the third quarter of last year, up from 18 hedge funds at the conclusion of the second quarter of the same year. This shows hedge fund sentiment around Dynavax Technologies Corporation (NASDAQ:DVAX) is positive. The biggest stakeholder of Dynavax Technologies Corporation (NASDAQ:DVAX) as of the end of the third quarter of 2022 was Ken Fisher’s Fisher Asset Management which owns a $44 million stake in the firm.